AI-based Biomarker Detection from Histopathology

About Imagene AI

Imagene AI, founded in 2020, is a private, early-revenue stage company developing a proprietary Cross-Modality Intelligence Engine for precision oncology. Its SaaS platform, the Oncology Intelligence (OI) Suite, leverages AI on histopathology images and multimodal data to accelerate biomarker discovery, patient stratification, and trial optimization. The company has established key partnerships with industry leaders like Tempus and Oracle Cloud Infrastructure to deploy its technology, positioning it at the intersection of AI diagnostics and biopharma R&D.

Therapeutic Areas